Cochlear Limited (ASX:COH – Get Free Report) insider Christine McLoughlin acquired 200 shares of the stock in a transaction dated Friday, February 28th. The stock was bought at an average price of A$261.73 ($162.57) per share, for a total transaction of A$52,346.00 ($32,513.04).
Cochlear Stock Performance
The company has a debt-to-equity ratio of 13.24, a quick ratio of 1.93 and a current ratio of 2.30. The company has a market capitalization of $19.88 billion, a price-to-earnings ratio of 55.90, a price-to-earnings-growth ratio of 3.87 and a beta of 0.47.
Cochlear Increases Dividend
The firm also recently declared a Interim dividend, which will be paid on Sunday, April 13th. Shareholders of record on Sunday, April 13th will be paid a dividend of $2.15 per share. The ex-dividend date is Wednesday, March 19th. This represents a yield of 0.78%. This is an increase from Cochlear’s previous Interim dividend of $2.00. Cochlear’s payout ratio is currently 77.35%.
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than Cochlear
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
- How to Invest in Insurance Companies: A Guide
- Zoom Stock: Leading the Video Market After Skype’s Exit
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intuitive Machines: March 6 Is a Pivotal Day for Lunar Economy
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
